Akari Therapeutics, Plc
AKTX
$1.19
$0.098.18%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/21/2025
-
Ticker Report
3/20/2025
-
GuruFocus
3/20/2025
-
Seeking Alpha - Healthcare
3/20/2025
-
TipRanks Financial Blog
3/20/2025
-
The Fly
3/20/2025
-
Globe Newswire
3/13/2025
-
Zolmax
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
The Fly
3/3/2025
-
GuruFocus
3/3/2025
-
Globe Newswire
2/22/2025
-
Ticker Report
2/19/2025
-
Globe Newswire
2/3/2025
-
The Fly
2/3/2025
-
GuruFocus
2/3/2025
-
Globe Newswire
1/29/2025
-
Ticker Report
1/29/2025
-
Ticker Report
1/22/2025
-
Ticker Report
1/16/2025
-
Ticker Report
1/14/2025
-
Ticker Report
1/5/2025
-
Ticker Report
12/30/2024
-
Ticker Report
12/29/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, November 19, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
929 274 7510
Address
22 Boston Wharf Road
Boston, MA 02210
Boston, MA 02210
Country
Year Founded
--
Business Description
Sector
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a...
more
